Extension of hydrogen peroxide as a biocide: what changes for disinfection companies in 2026

Key data

If your company manufactures, distributes or uses hydrogen peroxide-based disinfectants in industrial, healthcare, veterinary or food environments, this decision directly affects you — and the good news is that it does not require immediate action.

Commission Implementing Decision (EU) 2026/2131, published on 25 September 2026, delays the expiration date of the approval of hydrogen peroxide as an active substance in biocides of product types 1, 2, 3, 4 and 5. The measure is based on Regulation (EU) No 528/2012 on the marketing and use of biocides and responds to the need to complete the evaluation process without interrupting the availability of these products in the European market.

What does this regulation establish?

Hydrogen peroxide is one of the most widely used active substances in biocidal products for everyday and industrial use. European regulations require these substances to undergo a periodic evaluation process to maintain their approval. When that process takes longer than expected, the Commission can — and in this case does — delay the expiration date to prevent products from losing legal coverage before the review is completed.

This decision affects five specific product types (PT), each with well-defined uses:

The extension does not modify the conditions of use or technical requirements of already authorized products. It simply extends the period during which the approval of the active substance remains valid, giving time for the scientific evaluation to be completed rigorously.

Economic and operational impact

For companies in the sector, the immediate impact is neutral in terms of costs: there are no new fees, no additional registration obligations and no need to reformulate products or update labels as a direct consequence of this decision.

The real impact is one of operational continuity: without this extension, biocidal products with hydrogen peroxide would have lost legal coverage upon reaching the original expiration date, which would have forced their withdrawal from the market or the processing of emergency authorizations. The decision eliminates that risk.

The operational aspects to consider are:

• Existing product authorizations: remain valid without the need for early renewal.
• Supply contracts: are not affected by this decision.
• Ongoing evaluation process: the scientific evaluation continues. When completed, new conditions of use or restrictions could result. This is the time to follow that process closely.
• Medium-term planning: companies must be prepared to adapt their products when the final evaluation resolution is published.

Who does it affect?

This regulation is directly relevant to:

• Biocide manufacturers using hydrogen peroxide as an active substance in products of types PT 1 to PT 5.
• Distributors and marketers of disinfectants for human, veterinary, food or drinking water use.
• Industrial disinfection companies that apply these products in production, logistics or healthcare facilities.
• Food and feed industry using PT 4 biocides for disinfection of equipment and surfaces in contact with food.
• Veterinary clinics, farms and animal breeding centers using PT 3 biocides.
• Drinking water facility managers using hydrogen peroxide in PT 5 treatment.
• Compliance officers and operations directors in companies in the above sectors.

Practical example

A disinfectant manufacturer for the food industry markets a PT 4 biocidal product based on hydrogen peroxide, authorized under Regulation (EU) 528/2012. Its product authorization references the approval of the active substance, which was about to expire.

Without Commission Implementing Decision (EU) 2026/2131, this company would have had to initiate an urgent re-authorization process or temporarily withdraw the product from the market, with the resulting impact on sales, contracts with food sector customers and possible penalties for marketing a product without legal coverage.

With the extension in force, the company can continue manufacturing and marketing the product without any changes to its documentation or processes. Its only obligation is to monitor the progress of the European evaluation to anticipate possible changes when it concludes.

What should companies do now?

1. Verify which product types (PT) you use: confirm whether your hydrogen peroxide biocidal products belong to types PT 1, PT 2, PT 3, PT 4 or PT 5. If so, you are covered by this extension.
2. Review current product authorizations: check that your product authorizations reference the approval of hydrogen peroxide under Regulation (EU) 528/2012. No documentary updates are required at this time.
3. Inform your operations and compliance team: communicate that there are no immediate operational changes, but that the evaluation process is ongoing and may result in new conditions in the future.
4. Establish a regulatory alert system: monitor the progress of the European evaluation of hydrogen peroxide. When it concludes, new use restrictions, concentration limits or labeling requirements may be published that will require adaptations.
5. Review contracts with customers and suppliers: if you have regulatory compliance clauses in biocide supply contracts, confirm that the extension covers the current contract period.

Official source

Consult full regulation in official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602131